BEATcc: Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer Last updated on Jun 8, 2026 Previous Publications Update # 42 Next MITO-7: Weekly chemotherapy in ovarian cancer
